OPKO Health Report Q3 2024 Business Highlights & Financial Results
07 Nov 2024 //
GLOBENEWSWIRE
OPKO Report Q3 2024 Financial Results on November 7, 2024
29 Oct 2024 //
GLOBENEWSWIRE
ModeX Secures $51 Million For COVID And Influenza Programs
07 Oct 2024 //
GLOBENEWSWIRE
Entera Bio And OPKO Health Update On Peptide Tablet Results
25 Sep 2024 //
GLOBENEWSWIRE
ModeX Therapeutics Names Dr Abbadessa As Chief Medical Officer
23 Sep 2024 //
GLOBENEWSWIRE
OPKO Health Reports Q2 2024 Business Highlights And Financial Results
07 Aug 2024 //
GLOBENEWSWIRE
OPKO Health to Report Second Quarter 2024 Financial Results on August 7, 2024
01 Aug 2024 //
GLOBENEWSWIRE
OPKO Health Announces $100 Million Share Repurchase Program
18 Jul 2024 //
GLOBENEWSWIRE
OPKO And HealthCare Royalty Sign $250M Note Purchase Deal
17 Jul 2024 //
GLOBENEWSWIRE
OPKO Health to Participate in the Jefferies Global Healthcare Conference
31 May 2024 //
GLOBENEWSWIRE
OPKO Health Reports First Quarter 2024 Business Highlights and Financial Results
06 May 2024 //
GLOBENEWSWIRE
OPKO Health to Report First Quarter 2024 Financial Results on May 7, 2024
03 May 2024 //
GLOBENEWSWIRE
AIDS Trial Group Presents Results from Phase 1 of ModeX Trispecific Antibody
05 Mar 2024 //
GLOBENEWSWIRE
OPKO Reports Fourth Quarter 2023 Business Highlights and Financial Results
27 Feb 2024 //
GLOBENEWSWIRE
OPKO Health to Report Fourth Quarter 2023 Financial Results on February 27, 2024
22 Feb 2024 //
GLOBENEWSWIRE
OPKO Announces Closing of Private Offering of $230M Senior Notes
09 Jan 2024 //
GLOBENEWSWIRE
OPKO Health to Present at the 42nd Annual J.P. Morgan Healthcare Conference
08 Jan 2024 //
GLOBENEWSWIRE
OPKO Health Announces Private Offering of Convertible Senior Notes Due 2029
03 Jan 2024 //
GLOBENEWSWIRE
OPKO Health Reports Third Quarter 2023 Business Highlights and Financial Results
06 Nov 2023 //
GLOBENEWSWIRE
New Clinical Data on OPKO Health™s RAYALDEE Presented at Kidney Week 2023
02 Nov 2023 //
GLOBENEWSWIRE
OPKO Health to Report Third Quarter 2023 Financial Results on November 6, 2023
31 Oct 2023 //
GLOBENEWSWIRE
OPKO Health to Present New Clinical Data on Rayaldee at Kidney Week 2023
25 Oct 2023 //
GLOBENEWSWIRE
ModeX Secures BARDA Contract to Develop Novel Multispecific Antibodies
28 Sep 2023 //
GLOBENEWSWIRE
OPKO Health Reports Second Quarter 2023 Business Highlights & Financial Results
03 Aug 2023 //
GLOBENEWSWIRE
OPKO Health to Report Second Quarter 2023 Financial Results on August 3, 2023
25 Jul 2023 //
GLOBENEWSWIRE
OPKO Health Reports 1Q 2023 Business Highlights and Financial Results
03 May 2023 //
GLOBENEWSWIRE
OPKO Health to Report First Quarter 2023 Financial Results on May 3, 2023
25 Apr 2023 //
GLOBENEWSWIRE
OPKO Health to Hold Virtual R&D Day on March 20, 2023
09 Mar 2023 //
GLOBENEWSWIRE
Merck, Opko Health sign deal for experimental Epstein-Barr virus vaccine
09 Mar 2023 //
REUTERS
ModeX Enters into Agreement with Merck to Develop Epstein-Barr Virus Vaccine
08 Mar 2023 //
GLOBENEWSWIRE
OPKO Health Reports Q4 2022 Business Highlights and Financial Results
23 Feb 2023 //
GLOBENEWSWIRE
OPKO Health to Report Fourth Quarter 2022 Financial Results on February 23, 2023
16 Feb 2023 //
GLOBENEWSWIRE
OPKO Health to Present at the 41st Annual J.P. Morgan Healthcare Conference
03 Jan 2023 //
GLOBENEWSWIRE
OPKO Health Reports Third Quarter 2022 Business Highlights and Financial Results
08 Nov 2022 //
GLOBENEWSWIRE
OPKO Health to Report Third Quarter 2022 Financial Results on November 8, 2022
01 Nov 2022 //
GLOBENEWSWIRE
OPKO Health Reports 2022 Second Quarter Financial Results
04 Aug 2022 //
GLOBENEWSWIRE
OPKO Health to Report Second Quarter 2022 Financial Results on August 4, 2022
25 Jul 2022 //
GLOBENEWSWIRE
OPKO Health to Present at the 2022 Jefferies Healthcare Conference
02 Jun 2022 //
GLOBENEWSWIRE
OPKO Health Acquires ModeX Therapeutics
09 May 2022 //
GLOBENEWSWIRE
OPKO Health Reports 2022 First Quarter Business Highlights and Financial Results
09 May 2022 //
GLOBENEWSWIRE
OPKO Health to Report First Quarter 2022 Financial Results on May 9, 2022
05 May 2022 //
GLOBENEWSWIRE
OPKO Health Reports 2021 Q4 Business Highlights and Financial Results
24 Feb 2022 //
GLOBENEWSWIRE
EC grants marketing authorisation for Pfizer-OPKO’s Ngenla injection
15 Feb 2022 //
PHARMACEUTICAL-TECHNOLOGY
RAYALDEE Launched in Germany by OPKO Health’s Licensee, VFMCRP
03 Feb 2022 //
GLOBENEWSWIRE
MHLW Approves Pfizer and OPKO’s NGENLA for Pediatric Growth Hormone Deficiency
20 Jan 2022 //
GLOBENEWSWIRE
OPKO Health Announces Topline Data from Phase 2 Trial of Rayaldee
24 Dec 2021 //
TRIALSITENEWS
OPKO Health Announces Participation in Piper Sandler 33rd VHC
29 Nov 2021 //
GLOBENEWSWIRE
HealthSnap Secures $5M Investment Led by OPKO Health
11 Nov 2021 //
BUSINESSWIRE
Taysha, GeneDx Announces Sponsored Genetic Testing for Giant Axonal Neuropathy
13 Oct 2021 //
BUSINESSWIRE
US FDA extends review period for Pfizer & OPKO’s BLA of somatrogon
27 Sep 2021 //
PHARMABIZ
FDA extends review period for Pfizer and OPKO Health`s somatrogon BLA
24 Sep 2021 //
SEEKINGALPHA
LeaderMed, OPKO Health form JV for oxyntomodulin and Factor VIIa-CTP
15 Sep 2021 //
PHARMABIZ
LeaderMed Group and OPKO Health Form Joint Venture to Develop and Oxyntomodulin
14 Sep 2021 //
GLOBENEWSWIRE
OPKO Health completes enrollment in phase 2 trial of Rayaldee to treat Covid-19
01 Sep 2021 //
PHARMABIZ
OPKO Health Completes Enrollment in PII Trial of RAYALDEE for COVID-19 patients
30 Aug 2021 //
GLOBENEWSWIRE
Ascendis wins approval for once-weekly growth hormone drug as Pfizer
27 Aug 2021 //
ENDPTS
BioReference Labs buys centralized lab prenatal testing business from Roche.
18 Aug 2021 //
PHARMABIZ
OPKO Health Reports 2021 2nd Quarter Business Highlights and Financial Results
29 Jul 2021 //
GLOBENEWSWIRE
OPKO Health enters agreement with CAMP4 Therapeutics
12 Jul 2021 //
PHARMABIZ
OPKO Health enters agreement with CAMP4 Therapeutics
12 Jul 2021 //
PHARMABIZ